GoodRx Holdings Inc (GDRX)
7.10
+0.09
(+1.28%)
USD |
NASDAQ |
May 03, 16:00
7.115
+0.02
(+0.21%)
After-Hours: 20:00
GoodRx Holdings Cash from Operations (TTM): 138.29M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 138.29M |
| September 30, 2023 | 154.30M |
| June 30, 2023 | 127.76M |
| March 31, 2023 | 148.95M |
| December 31, 2022 | 146.78M |
| September 30, 2022 | 164.71M |
| June 30, 2022 | 179.54M |
| Date | Value |
|---|---|
| March 31, 2022 | 163.41M |
| December 31, 2021 | 178.78M |
| September 30, 2021 | 143.82M |
| June 30, 2021 | 127.93M |
| March 31, 2021 | 131.23M |
| December 31, 2020 | 131.34M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
127.76M
Minimum
Jun 2023
179.54M
Maximum
Jun 2022
148.99M
Average
146.78M
Median
Dec 2022
Cash from Operations (TTM) Benchmarks
| Sharecare Inc | -13.97M |
| American Well Corp | -148.34M |
| MultiPlan Corp | 171.72M |
| Privia Health Group Inc | 80.78M |
| GeneDx Holdings Corp | -141.00M |